{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:33:29Z","timestamp":1791977609958,"version":"4.4.0"},"reference-count":14,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,8,2]],"date-time":"2005-08-02T00:00:00Z","timestamp":1122940800000},"content-version":"vor","delay-in-days":1919,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2000,5]]},"abstract":"<jats:p><jats:bold>Summary: <\/jats:bold>  <jats:italic>Purpose<\/jats:italic>: To determine whether methsuximide (MSM) affects lamotrigine (LTG) blood levels and whether any change is of clinical significance.<\/jats:p><jats:p> <jats:italic>Methods<\/jats:italic>: LTG serum levels in 16 patients taking MSM were compared with those before starting or after stopping the MSM. The 16 patients, (11 boys, five girls) were young people (mean age, 15.5 years; range, 9\u201319 years) with a variety of seizure types and syndromes. In six cases, LTG levels were available both before MSM was started and after it was stopped.<\/jats:p><jats:p> <jats:italic>Results<\/jats:italic>: The mean LTG serum concentration before starting or after stopping MSM was 13.4 mg\/L, and the mean level while taking MSM was 6.3 mg\/L. This difference was highly significant (p &lt; 0.0005, paired <jats:italic>t<\/jats:italic> test). MSM lowered the LTG serum concentration in every case, with a mean decrease of 53% (range, 36\u201372%). In some patients this led to a deterioration in seizure control when MSM was added or an improvement in seizure control after MSM was stopped.<\/jats:p><jats:p> <jats:italic>Conclusions<\/jats:italic>: Although MSM is a valuable add\u2010on, broad\u2010spectrum drug when used in combination with LTG, adjustment of the LTG dose may be necessary when MSM is started or stopped, to allow for the fact that MSM lowers LTG blood levels.<\/jats:p>","DOI":"10.1111\/j.1528-1157.2000.tb00218.x","type":"journal-article","created":{"date-parts":[[2005,8,3]],"date-time":"2005-08-03T06:37:14Z","timestamp":1123051034000},"page":"624-627","source":"Crossref","is-referenced-by-count":35,"title":["Methsuximide Lowers Lamotrigine Blood Levels: A Pharmacokinetic Antiepileptic Drug Interaction"],"prefix":"10.1111","volume":"41","author":[{"given":"F. M. C.","family":"Besag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,2]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1542\/peds.87.2.186","article-title":"Methsuximide for intractable childhood seizures","volume":"87","author":"Tennison MB","year":"1991","journal-title":"Pediatrics"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1986.tb03514.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.31.6.741"},{"key":"e_1_2_1_5_2","first-page":"1503","volume-title":"Epilepsy: a comprehensive textbook","author":"Bromfield EB.","year":"1997"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.4.414"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(96)80062-8"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1979.tb04787.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1979263366"},{"key":"e_1_2_1_10_2","first-page":"25","article-title":"Methsuximide lowers LTG blood levels: a pharmacokinetic AED interaction [Abstract]","volume":"39","author":"Besag FMC","year":"1998","journal-title":"Epilepsia"},{"key":"e_1_2_1_11_2","first-page":"25","article-title":"Influence of oxcarbamazepine and methsuximide on LTG concentrations [Abstract]","volume":"39","author":"May TW","year":"1998","journal-title":"Epilepsia"},{"key":"e_1_2_1_12_2","first-page":"41","article-title":"Lamotrigine: a novel approach","volume":"3","author":"Meldrum BS.","year":"1994","journal-title":"Seizure"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/0883073897012001041"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(91)90012-5"},{"key":"e_1_2_1_15_2","unstructured":"BerryDJ WicksJFC ClarkeLA.Determination of lamotrigine in human plasma by reversed phase HPLC.HPLC \u203292(abst no 183)."}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1528-1157.2000.tb00218.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1528-1157.2000.tb00218.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T18:11:55Z","timestamp":1695838315000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1528-1157.2000.tb00218.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["10.1111\/j.1528-1157.2000.tb00218.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1528-1157.2000.tb00218.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}